On May 4, 2021 Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing novel T cell-based cancer immunotherapies, reported that senior leadership plans to present at the following virtual conferences in May (Press release, Iovance Biotherapeutics, MAY 4, 2021, View Source [SID1234579173]):
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Truist Securities Life Sciences Summit
Fireside Chat: Wednesday, May 5 at 12:10 p.m. ET
Live and archived webcast: available at View Source
Inaugural Multi-Functional Cell Therapies Summit
Presentation: Leveraging TILs to Engage Solid Tumors as a Natural Multi-Targeted Approach
Date/Time: Thursday, May 6 at 12:00 p.m. ET
More information: View Source
17th Annual PEGS Boston Virtual Conference & Expo
Presentation: Investigating the Power of Tumor Infiltrating Lymphocytes for Treatment of Cancer
Date/Time: Thursday, May 13 at 2:20 p.m. ET
More information: https://www.pegsummit.com/
Sachs Associates 7th Annual Immuno-Oncology Innovation Forum
Keynote Presentation: Tumor Infiltrating Lymphocyte Cell Therapy for Treatment of Solid Tumors
Date/Time: Wednesday, May 19 at 12:30 p.m. ET
More information: View Source